Answers are grounded in this paper and cite their sources.
This study demonstrates green banana flour's ability to reduce TMAO in obese individuals, suggesting cardiovascular benefits.
The trimethylamine N-oxide (TMAO) uremic toxin is produced after the fermentation of choline, L-carnitine, and phosphatidylcholine. The high amount of TMAO, in the bloodstream, seems to stimulate the atherosclerosis process, which compromises the cardiovascular system. In the present study, we assessed the TMAO-reducing effect of a new nutraceutical formulation, containing green banana flour, in humans. Methodology: We assessed the amount of serum TMAO via liquid chromatography (HPLC). As to nutritional diagnosis, patients presented with grade II obesity (BMI = 35 to 39.9 kg/m2) in all nutritional assessment intervals. Reduced food intake was correlated with greater satiety provided by the consumption of green banana flour. The average reduction was 722 kcal/day, a result that was considered significant (p=0.0284). As to the reduction in the TMAO levels of the obese patients assisted after the GBF use, there was a significant statistical difference at p<0.0004 when compared to the group that only used diet therapy. In conclusion, our data show that green banana flour can represent a new and useful source of food fiber capable of reducing cardiovascular risks. Without a doubt, more in vitro and in vivo studies should be performed to elucidate possible action mechanisms and corroborate these preliminary results.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: